deltatrials
Unknown NA INTERVENTIONAL 3-arm NCT06191822

Aspire2B Personalization Pilot Study Program

Sponsor: PepsiCo Global R&D

Updated 4 times since 2024 Last updated: Jan 2, 2024 Started: Mar 1, 2022 Primary completion: Jun 30, 2024 Completion: Jun 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06191822, this NA trial focuses on App Proficiency and Behavior and remains ongoing. Sponsored by PepsiCo Global R&D, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Feb 2026 — Present [monthly]

    Unknown NA

    Status: RecruitingUnknown

  2. Sep 2024 — Feb 2026 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • PepsiCo Global R&D
Data source: PepsiCo Global R&D

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations